top of page
logo
ACCESS FORUM

U.S. Laws on Psychedelic Mushrooms vs LSD

  • Writer: jamesbanky71
    jamesbanky71
  • Apr 6
  • 4 min read

Psychedelic substances like mushrooms and LSD have sparked growing interest for their potential therapeutic benefits and cultural significance. Yet, their legal status in the United States remains complex and often confusing. This post breaks down the key differences and similarities in U.S. laws regarding psychedelic mushrooms and LSD, helping you understand how these substances are regulated and what that means for users, researchers, and policymakers.


Close-up view of dried psychedelic mushrooms on a wooden surface
Close-up of dried psychedelic mushrooms on wood

What Are Psychedelic Mushrooms and LSD?


Psychedelic mushrooms, often called "magic mushrooms," contain psilocybin, a naturally occurring psychedelic compound. When ingested, psilocybin converts to psilocin, which affects serotonin receptors in the brain, leading to altered perception, mood, and cognition.


LSD (lysergic acid diethylamide) is a synthetic psychedelic first synthesized in 1938. It is known for its powerful hallucinogenic effects, which can last up to 12 hours. LSD acts primarily on serotonin receptors, similar to psilocybin, but its chemical structure and potency differ.


Both substances have been studied for potential benefits in treating depression, PTSD, and anxiety, but their legal status remains restrictive.


Federal Legal Status of Psychedelic Mushrooms and LSD


At the federal level, both psychedelic mushrooms and LSD are classified as Schedule I substances under the Controlled Substances Act (CSA). Schedule I drugs are defined as having:


  • High potential for abuse

  • No currently accepted medical use in treatment

  • Lack of accepted safety under medical supervision


This classification means possession, distribution, or manufacture of these substances is illegal under federal law, punishable by fines and imprisonment.


Key Points About Federal Law


  • Psilocybin and psilocin (the active compounds in psychedelic mushrooms) are Schedule I substances.

  • LSD is also Schedule I.

  • The law does not distinguish between naturally occurring psilocybin mushrooms and synthetic LSD in terms of legality.

  • Research involving these substances requires special licenses from the Drug Enforcement Administration (DEA).


State Laws Vary Widely


While federal law prohibits both substances, some states and cities have taken steps to decriminalize or deprioritize enforcement related to psychedelic mushrooms and, less commonly, LSD.


Psychedelic Mushrooms


  • Oregon became the first state to legalize psilocybin for supervised therapeutic use in 2020 through Measure 109. This allows licensed providers to administer psilocybin in controlled settings.

  • Several cities, including Denver (Colorado), Oakland and Santa Cruz (California), and Seattle (Washington), have decriminalized possession and use of psilocybin mushrooms. This means law enforcement treats possession as a low priority.

  • Other states have introduced bills to decriminalize or legalize psilocybin, but most remain illegal.


LSD


  • LSD remains illegal in all states, with no states or cities having passed laws to decriminalize or legalize it.

  • Some local jurisdictions may deprioritize enforcement, but this is rare and not formalized.

  • LSD’s synthetic nature and longer duration of effects contribute to its stricter local regulation compared to psilocybin mushrooms.


Differences in Legal Treatment Between Psychedelic Mushrooms and LSD


The legal landscape shows clear differences in how psychedelic mushrooms and LSD are treated:


| Aspect | Psychedelic Mushrooms | LSD |

|-------------------------|----------------------------------------------|------------------------------------|

| Federal Classification | Schedule I | Schedule I |

| State Legal Status | Some states/cities decriminalize or legalize | Illegal in all states |

| Medical Use | Oregon allows supervised therapeutic use | No state allows medical use |

| Research Access | Requires DEA license, but increasing interest | Requires DEA license, tightly controlled |

| Public Perception | Growing acceptance, especially for therapy | More stigmatized, less public support |


Why Are Psychedelic Mushrooms Treated More Leniently in Some Places?


Several factors explain why psilocybin mushrooms have seen more leniency:


  • Natural origin: Mushrooms grow naturally and have been used in indigenous rituals for centuries.

  • Shorter duration: Effects last 4-6 hours, shorter than LSD’s 8-12 hours.

  • Emerging research: Clinical trials show promising results for mental health treatment.

  • Public advocacy: Strong grassroots campaigns have pushed for reform.


LSD’s synthetic origin, longer effects, and historical association with counterculture movements have slowed reform efforts.


Legal Risks and Consequences


Possession or distribution of either substance can lead to serious legal consequences:


  • Possession: Can result in misdemeanor or felony charges, fines, and jail time.

  • Distribution or trafficking: Carries harsher penalties, including long prison sentences.

  • Paraphernalia: Items used to consume or grow mushrooms may also be illegal.

  • Federal vs. state conflict: Even in states that decriminalize psilocybin, federal law enforcement can still prosecute.


Research and Medical Use


Despite legal restrictions, research on both substances is expanding:


  • The FDA has granted “breakthrough therapy” status to psilocybin for depression.

  • Clinical trials for LSD-assisted therapy have resumed after decades.

  • Research requires strict regulatory approval and DEA licenses.


Oregon’s psilocybin program is the first state-regulated therapeutic model, with licensed facilitators guiding patients through sessions.


Eye-level view of a laboratory setup with psychedelic research equipment
Laboratory setup for psychedelic research with glassware and instruments

What This Means for Users and Advocates


Understanding the legal landscape helps users and advocates navigate risks and opportunities:


  • Users should be aware of local laws and potential federal risks.

  • Advocates can focus efforts on education, policy reform, and supporting research.

  • Healthcare providers should follow legal guidelines and stay informed about emerging therapies.

  • Researchers must comply with strict regulations but can contribute to changing perceptions.


Final Thoughts on U.S. Laws for Psychedelic Mushrooms and LSD


The legal status of psychedelic mushrooms and LSD in the U.S. reflects a mix of history, science, and social attitudes. While both remain illegal federally, psilocybin mushrooms have gained more acceptance at the state and local levels, especially for therapeutic use. LSD continues to face stricter controls and stigma.


Anyone interested in these substances should stay informed about evolving laws and approach use with caution. The growing body of research and shifting public opinion suggest the legal landscape may continue to change in the coming years.


If you want to learn more or get involved, consider following local policy developments or supporting organizations focused on drug policy reform and psychedelic research.




































































































 
 
 

Comments

bottom of page